A Phase 1B, Multicenter, Randomized, Double-masked, Controlled Study to Evaluate the Efficacy and Safety of a Fixed Combination Bimatoprost/Timolol Ocular Insert Compared to Its Individual Components With Crossover to Timolol 0.5% in Subjects With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Phase of Trial: Phase I/II
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Bimatoprost/timolol (Primary) ; Bimatoprost; Timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors ForSight VISION5
- 14 Feb 2017 Status changed from active, no longer recruiting to completed.
- 08 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Apr 2016 New trial record